NCT03907475 2026-04-13Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ TrialNational Cancer Institute (NCI)Phase 2 Recruiting115 enrolled
NCT07044336 2026-04-13Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)AstraZenecaPhase 3 Recruiting700 enrolled
NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled